Vol. 282, Issue 4, H1181-H1188, April 2002
1-Receptors increase cAMP and induce abnormal
Cai cycling in the German shepherd sudden death
model
Susan F.
Steinberg1,
Sasha
Alcott1,
Elena
Pak1,
Donglei
Hu1,
Lev
Protas1,
N. Sydney
Möise2,
Richard B.
Robinson1, and
Michael R.
Rosen1
1 Center for Molecular Therapeutics, Departments of
Pharmacology, Medicine and Pediatrics, College of Physicians and
Surgeons of Columbia University, New York 10032;
and 2 Cornell University, College of Veterinary
Medicine, Ithaca, New York 14853-6401
 |
ABSTRACT |
We studied the role of
-adrenergic
receptor subtype signaling to cAMP and calcium in the genesis of
catecholamine-dependent arrhythmias in German shepherd dogs that
develop lethal arrhythmias at ~5 mo of age. There were three major
findings in this study: 1) isoproterenol induces similar
increases in cAMP in afflicted and control dogs exclusively through
1-receptors (not
2), 2) cells
from afflicted dogs display prolonged relaxation kinetics at long cycle
lengths and large frequent spontaneous calcium oscillations (and
aftercontractions) with little increase in calcium transient amplitude
in response to
1-receptor agonists, and 3)
2-receptor agonists induce a similar marked increases in
calcium transient and twitch amplitude, with only rare spontaneous
calcium oscillations in afflicted and control cells. These results
indicate that catecholamines provide inotropic support to canine
cardiomyocytes through distinct
1- and
2-receptor pathways with differing requirements for
cAMP. The propensity to develop arrhythmias is not induced by
2-receptors (or a rise in calcium alone), but rather
occurs in the context of
1-receptor activation of the
cAMP-dependent pathway.
cardiac arrhythmia;
-adrenergic receptors; afterdepolarization; aftercontractions; calcium
 |
INTRODUCTION |
GERMAN SHEPHERD DOGS
that develop lethal ventricular tachycardias from 4 to 6 mo of age have
become a useful tool to explore mechanisms that mediate
catecholamine-dependent arrhythmias in the young (3, 10, 11,
15). These animals manifest delayed maturation of sympathetic
innervation of the anterospetal left ventricle (2) and two
types of arrhythmias: those which are pause dependent and potentiated
by
-adrenergic receptor stimulation of the Purkinje system (3,
15) and those which are tachycardia initiated and secondary to
delayed afterdepolarization-induced triggered activity in the
myocardium (15). The latter mechanism is mediated by
1- (but not
2) receptor-dependent
mechanisms (16). In view of recent evidence that
cardiomyocyte
1- and
2-adrenergic
receptors can exhibit distinct signaling properties (17),
the present study examines
-adrenergic receptor subtype linkage to
downstream effectors. The goal is to determine the extent to which
differences in the propensity of the afflicted animals to develop
arrhythmias can be attributed to differences in
1-
versus
2-adrenergic receptor signaling to the cAMP
pathway and/or the modulation of intracellular calcium.
 |
METHODS |
We studied 11 German shepherd dogs from an inbred colony at
20-25 wk of age that were identified as having lethal arrhythmias via previously described electrocardiogram monitoring techniques (10, 11). Eight unrelated German shepherd dogs of the same age without arrhythmias served as controls. Animals were anesthetized with pentobarbital sodium (30 mg/kg), and the hearts were excised via a
thoracotomy and placed in ice-cold Tyrode's solution. The anteroseptal
and posterobasal regions of the left ventricle were identified as
previously (15) and were cut away from the remaining myocardium. Cell preparation was as described below.
Materials.
Reagents were purchased commercially from the following sources: fura
2-acetoxymethyl ester (AM) (Molecular Probes), ICI-188551 (Cambridge
Research Biochemicals), forskolin (Sigma). CGP-20712A was purchased
from Ciba-Geigy (Berne, Switzerland) and zinterol was a generous gift
from Bristol-Myers Squibb (Wallingford, CT). All other chemicals were
reagent grade.
Cell isolation.
Anteroseptal (AS) and posterobasal (PB) regions of the left ventricle
were dissected and perfused through the left anterior descending or
left circumflex coronary artery, respectively. Collagenase dissociation
was conducted as originally described by Hewett et al. (4)
and subsequently modified according to the method of Hoffman et al.
(5, 6). It employs a variation on the Langendorff perfusion where only a perfused wedge of left ventricular free wall
(with cut vessels that were tied off or stapled closed) is used, rather
than the entire heart, and perfusion is maintained with a roller pump
rather than gravity. The roller pump maintains flow through the heart
wedge at about 10 ml/min. The wedge is perfused with a collagenase, the
epicardial and endocardial surfaces are then trimmed away, and the
remaining tissue minced and triturated in an additional series of
collagenase solutions to produce isolated myocytes.
cAMP measurements.
Cells from the AS or PB regions of the ventricle were preincubated for
60 min at room temperature with 10 mM theophylline. Assays were
performed in the absence or presence of agonist for 5 min at room
temperature and were terminated by removal of the incubation buffer and
the addition of 1 ml of ethanol. Each condition was assayed in
duplicate, with cAMP measured in quadruplicate. Aliquots of the
alcohol-fixed cell extract were dried under a stream of nitrogen, and
cAMP in the residue was determined using a radioimmunoassay (DuPont-New
England Nuclear; Wilmington, DE).
Measurements of calcium transients and twitches.
Myocytes were loaded with fura 2-acetoxymethyl ester (AM) by incubation
for 20 min at 37°C with 3 mM fura 2-AM and 1.5 ml of 25% (wt/wt in
dimethyl sulfoxide) Pluronic F-127 (BASF Wyandotte) dissolved in 1.0 ml
Tyrode's solution. Myocytes were rinsed with fresh Tyrode's solution
and maintained for at least 15 min at room temperature to permit
deesterification of the dye before protocols. Intracellular fura 2 fluorescence was monitored (at a sampling rate of 100 Hz) with a device
that alternately illuminates the cells with 340 and 380 nm light while
it measures emission at 520 nm (Photon Technologies; Princeton, NJ).
Myocytes were superfused with room temperature Tyrode's solution
gassed with 95% O2-5% CO2 at a rate of 1 ml/min. The experimental protocol consisted of successive 1-min
intervals of electrical field stimulation at 1, 0.5, 0.2, and 0.1 Hz,
followed by pacing at 0.5 Hz during superfusion with
-receptor
agonist. Intracellular calcium is reported as the fura 2 fluorescence
ratio because of the uncertainties inherent in any attempt to calibrate
these signals (7).
To monitor cell motion, myocytes were simultaneously illuminated with
red light, and a dichroic mirror (630 nm cutoff) in the emission path
deflected the cell image to a video optical system (Crescent
Electronics), which tracked motion of the cell edges along a raster
line segment of the image during electrically stimulated contractions.
The analog voltage output from the motion detector was calibrated to
convert to microns of motion. The motion signal was obtained at a rate
of 60 Hz and reflected the motion of the same myocyte simultaneously
monitored with fura 2 for calcium. The digitized signal was stored
along with the fluorescence data.
Statistical analysis.
Data are presented as means ± SE. Statistical significance was
determined by ANOVA, Student's t-test, or Fisher's exact
test, as appropriate. P < 0.05 was regarded as significant.
 |
RESULTS |
-Adrenergic receptor activation of cAMP.
Figure 1 shows the results of cAMP
measurements on cells prepared from the AS and PB regions of control
and afflicted German shepherd dogs. Basal cAMP levels do not
significantly differ across control and afflicted groups and, in each
case, cAMP accumulation is markedly enhanced by exposure to
isoproterenol and forskolin (Fig. 1A). The
isoproterenol-dependent cAMP accumulation is blocked by the
1-adrenergic receptor antagonist CGP-20712A, but not by the
2-adrenergic receptor antagonist ICI-188551.
Similarly, zinterol, which is selective for the
2-adrenergic receptor at the concentration used
(7), induces no significant increase in cAMP accumulation. Although basal and stimulated levels of cAMP tend to be lower in the AS
region of afflicted dogs, the values do not differ across groups
(P > 0.05). Figure 1B displays the
concentration-response relationships for isoproterenol-dependent
cAMP accumulation; 50% effective concentrations for isoproterenol are
similar in each preparation.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 1.
Isoproterenol (Iso) promotes cAMP accumulation through
1-adrenergic receptors in cells from 5 control and 8 afflicted German shepherd dogs. A: cardiomyocytes were
challenged for 5 min with 10 7 M isoproterenol (in the
absence or in the presence of 10 7 M CGP-20712A (CGP) or
10 7 M ICI-188551 (ICI), each starting 5 min before
isoproterenol), or were exposed to 10 7 M zinterol or
10 6 M forskolin. All values for Iso and Iso + ICI-188551 differ from basal and Iso + CGP-20712A
(P < 0.05). Values for forskolin differ from basal
(P < 0.05); those for zinterol do not
(P > 0.05). B: cAMP accumulation in the
presence of increasing concentrations of isoproterenol. AS,
anteroseptal; PB, posterobasal.
|
|
Characteristics of the calcium transient and twitch.
Regulation of intracellular calcium depends on the integration of
processes regulating calcium entry and extrusion at the cell surface as
well as calcium release and reuptake at the sarcoplasmic reticulum.
Figure 2 compares amplitudes and kinetics
of calcium transients (Fig. 2A) and twitches (Fig.
2B). Cells isolated from both regions of control and
afflicted dogs display rate-dependent increases in amplitude and a
hastening of the kinetics of the calcium transient and the twitch. The
amplitudes of the calcium transients and twitches are similar across
all preparations [at all cycle lengths (CL)]. At 1 and 0.5 Hz, the
kinetics of the calcium transients and twitches also are not
distinguishable. However, at long CL (0.2 and 0.1 Hz), the calcium
transient and twitch kinetics of afflicted cells were slower than the
controls (P < 0.05).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
Calcium transient and twitch characteristics for cardiomyocytes.
Cardiomyocytes were electrically stimulated at 0.1-1 Hz. At each
stimulation rate 6 consecutive calcium transients (A) and
twitches (B) at steady state were signal averaged for
analysis of amplitude and duration at half-maximal amplitude. Results
from 59 cells from afflicted dogs and 23 cells from control dogs.
* P < 0.05 of corresponding region from control.
|
|
-Adrenergic receptor subtype modulation of intracellular
calcium.
To examine the functional consequences of cellular activation by
1- and
2-adrenergic receptor subtypes,
cardiomyocytes were exposed to progressively increasing concentrations
of isoproterenol (10
9-10
7 M) or to
10
7 M zinterol during continuous electrical stimulation
at 0.5 Hz. In control cells, the effect of isoproterenol on promoting
cAMP accumulation (see above) was accompanied by a marked increase in
the amplitude of the calcium transient and the twitch. Three cells from
the AS and PB regions of control dogs displayed spontaneous impulse
initiation and severe calcium overload at 10
7 M
isoproterenol. The remaining 14 control cells tolerated the study
protocol. Occasional oscillations of calcium accompanied by
aftercontractions that delayed the return of calcium to baseline values
and relaxation to resting cell length were observed during superfusion
with 10
7 M isoproterenol in 6 of 14 cells in the control
group (4 cells from the AS and 2 cells from the PB regions). However,
these were isolated events with amplitudes that never exceeded 10% of
the amplitude of the electrically stimulated twitch (as shown in Fig. 3).

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 3.
Representative record of the response to Iso in a cardiomyocyte
isolated from the AS region of a control dog. Note
concentration-dependent increase of calcium and motion during Iso
exposure.
|
|
The study of calcium transients and motion had to be aborted in 7 of 66 cells from afflicted dogs (P > 0.05 of control)
due to failure to sustain stable baseline conditions (i.e., spontaneous calcium transients and aftercontractions were prominent before the
initiation of superfusion with isoproterenol). Four cells that
sustained stable baseline electrically driven contractions (2 cells
from the AS region and 2 cells from the PB region) were exposed to
5 × 10
9 M isoproterenol. In marked contrast to
cells from control dogs, this concentration of isoproterenol induced a
60-100% increase in the amplitude of the electrically driven
twitch with little to no increase in the amplitude of the associated
calcium transient. Rather, isoproterenol induced frequent large
spontaneous calcium oscillations (accompanied by large
aftercontractions) that rapidly culminated in cell death terminating
each of these experiments (Fig. 4).

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 4.
Oscillations of calcium and aftercontractions induced by
10 8 M Iso in a cardiomyocyte isolated from the AS region
of an afflicted dog. The record is representative of results obtained
in 4 cells: 2 AS and 2 PB region from 2 separate cell isolations. Cell
death occurred within 2-5 min.
|
|
Given the toxicity of isoproterenol to cells from afflicted ventricles,
the protocol was revised to span a lower range of agonist
concentrations (5 × 10
10 to 5 × 10
9 M). Isoproterenol 5 × 10
10 M
evoked a substantial increment in the amplitude of the twitch (61 ± 4%) despite only a minor increase in the amplitude of the associated calcium transient (6 ± 2% n = 26, Fig. 5). This concentration of
isoproterenol generally was tolerated. However, at 5 × 10
9 M isoproterenol, all 15 AS and 11 PB cells developed
prominent calcium oscillations and aftercontractions, with no
significant additional increment in calcium transient or twitch
amplitudes. No regional differences in calcium and inotropic responses
(or cardiomyocyte susceptibility to the arrhythmogenic properties of
isoproterenol) were identified between AS and PB cells.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 5.
Representative record displaying the calcium oscillations and
aftercontractions induced by Iso in cardiomyocytes from afflicted dogs
(see text for discussion).
|
|
To distinguish potential contributions of
-adrenergic receptor
subtypes to catecholamine-dependent changes in calcium and cell motion,
eight cells were stimulated with 10
7 M zinterol to
selectively activate
2-adrenergic receptors. The response of a cell isolated from the AS region of an afflicted dog is
depicted in Fig. 6. This result is
typical of data obtained in myocytes from both regions of afflicted and
control dogs. Two points are noteworthy. First, zinterol elicited a
151 ± 32% increase in the magnitude of the twitch in association
with a 132 ± 22% increase in the amplitude of the calcium
transient. Interestingly, a similar level of inotropic support via
1-adrenergic receptors was unaccompanied by any change
in calcium transient amplitude in afflicted dogs (compare Figs. 5 and
6). Second, the zinterol-dependent increase in calcium only rarely
evoked oscillations of calcium in afflicted dogs, and these were
self-limited (in 2 of 8 cells). This indicates that the rise in calcium
alone is not sufficient to induce arrhythmias in cardiomyocytes from
afflicted dogs.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 6.
Response of a cardiomyocyte from the AS region of an afflicted dog
to 10 7 M zinterol. The record is representative of
responses obtained in cells from either region of afflicted or
control dogs (see text for discussion).
|
|
 |
DISCUSSION |
These results identify catecholamine-dependent inotropic support
in cardiomyocytes from control and afflicted dogs through distinct
1- and
2-adrenergic receptor pathways
(with differing requirements for cAMP); only catecholamine stimulation
of the cAMP-dependent
1-adrenergic receptor pathway (not
the
2-receptor pathway) leads to calcium oscillations
that are large, frequent, and associated with large frequent
aftercontractions in afflicted dogs. These abnormalities are likely to
contribute to the mechanism for catecholamine-induced ventricular
arrhythmias in this German shepherd model of spontaneous lethal
arrhythmias that develop during 4-6 mo of age.
As previously demonstrated (15), two types of arrhythmias
occur in this model: pause-dependent arrhythmias are enhanced by
-adrenergic stimulation and arrhythmias induced by rapid heart rates
are facilitated by
1-adrenergic stimulation. The latter have been attributed to triggered activity induced by delayed afterdepolarizations (15). Yet early afterdepolarization
(EAD)-dependent arrhythmias also may be facilitated by
-adrenergic
mechanisms, such that there is an increase in amplitude of EADs and
likelihood of triggered activity (20). This type of effect
is demonstrated in Figs. 4 and 5.
This study identifies two abnormalities in calcium cycling that may
contribute to the genesis of arrhythmias in afflicted animals. First,
cardiomyocytes from afflicted dogs are severely impaired in their
ability to "tolerate"
1-receptor stimulation; this
distinct biological property is manifest as the development of calcium
oscillations, severe calcium overload, and cell death during exposure
to typical concentrations of
1-receptor agonists (Fig.
4). Second, cardiomyocytes from afflicted dogs display increased duration of the calcium transient and prolonged twitch relaxation rates
at long CL (Fig. 2). Impaired calcium extrusion mechanisms are
predicted to contribute to arrhythmias that develop during the frequent
pauses that interrupt tachycardias or at times of marked variability in
heart rate both of which characteristics are seen frequently during
sinus rhythm in these animals (10, 11, 15). Candidate loci
for these defects in calcium handling include calcium regulatory
proteins in the sarcoplasmic reticulum, i.e., sarco(endo)plasmic
reticulum Ca2+-ATPase, phospholamban, and ryanodine
receptor, or plasma membrane (the Na/Ca exchanger). Many of these
proteins undergo developmental maturational processes that would be
susceptible to developmental dysregulation and would be pertinent to a
syndrome that displays an age-dependent phenotype. However, the slower
calcium transient relaxation kinetics of ventricular myocytes from
afflicted animals, that are manifest only at long CLs, may also be the
consequence of the longer action potential duration at slow drive
rates. Previous studies (15, 16) attributed this defect to
prolongation of the plateau. Whereas abnormalities of several channels
are possible, preliminary data suggest that the pathological phenotype
may be attributed at least in part to increased L-type calcium current in ventricular myocytes from afflicted but not control animals.
As noted in METHODS, the Ca signaling experiments were
performed at room temperature. It is true that action potential
configuration at room temperature and physiological temperature will
differ. However, it is important to note that the starting point for
the present study was our previous report that in ventricular tissue at
physiological temperature, isoproterenol but not zinterol induced more
triggered action potentials in afflicted than control animals (16). The present study employs isolated myocytes rather
than intact tissue, and measures Ca transients and cell shortening rather than electrical activity. However, the basic phenomenon is
clearly reproduced in the single cells even when studied at room
temperature (see Figs. 3 and 4). Thus the aftercontractions observed in
afflicted cells during isoproterenol exposure at room temperature are
completely compatible with results from the earlier study
(16) performed at physiological temperature.
The electrophysiological abnormalities in this model have been
attributed to
1- rather than
2-receptor
mechanisms (16). Although there is general agreement that
1-adrenergic receptors couple to the activation of
adenylyl cyclase and the generation of cAMP, the relative
role/importance of cardiomyocyte
2-adrenergic receptors
as an entrée into the cAMP-generating pathway (and as a mechanism
for inotropic support), has been the subject of recent controversy
(17). Solid evidence links
2-adrenergic receptors to the promotion of cAMP accumulation in certain
cardiomyocyte preparations, but the linkage of
2-adrenergic receptors to global increases in cAMP
appears to be highly contextual (17). Our present results
indicate that
2-adrenergic receptors markedly elevate
intracellular calcium and provide inotropic support in cardiomyocytes
from normal and afflicted German shepherd dogs. However, this occurs
via a pathway that is not associated with a detectable elevation of
cAMP. Although a localized increase in cAMP (confined to the membrane
compartment) in response to
2-receptor agonists cannot
be excluded, these experiments demonstrate that the
2-adrenergic receptor pathway is distinct from the
pathway emanating from
1-adrenergic receptors. Only
1-receptors induce a marked global increase in cAMP
formation and lead to pronounced abnormalities of cardiac rhythm.
Afflicted German shepherd dogs display excessive sensitivity to
1-adrenergic receptor activation; the
2-adrenergic receptor pathway is not measurably
different in tissues from afflicted and control animals.
We previously (15) performed biochemical measurements of
-adrenergic receptor density and activation of adenylyl cyclase in
membranes prepared from control and afflicted dogs in an effort to
identify the mechanism(s) that mediate enhanced sensitivity to
-adrenergic receptor stimulation. In that study,
-adrenergic receptor density was higher and basal isoproterenol-activated adenylyl
cyclase activity was greater in membranes prepared from the vulnerable
anteroseptal region of left ventricle of afflicted than the
corresponding region of control dogs, suggesting that a defect in
-adrenergic receptor signaling to cAMP formation may contribute to
the genesis of arrhythmias in this model (15). An
abnormality of rhythm and calcium handling attributable to
1-receptors (not
2) suggests the presence
of differences in
1- and
2-receptors
signaling to cAMP accumulation. Hence, the studies were extended to
discriminate the individual signaling phenotypes of cardiomyocyte
1- and
2-receptors. Because
2-adrenergic receptors constitute the minor subtype in
cardiomyocytes, but are the predominant
-receptor subtype in cardiac
fibroblasts that contaminate intact tissue preparations, the studies
were pursued in isolated cardiomyocyte preparations. This model, which provides the optimal strategy to evaluate integrated signaling from
-adrenergic receptors to adenylyl cyclase, provided evidence that
cAMP accumulates to high levels in response to
1-agonists and that the response is equivalent across
regions of the ventricle and between control and afflicted dogs.
Although cells from the vulnerable region of afflicted dogs display a
subtle generalized reduction in cAMP accumulation, including to
forskolin (compared with other regions of afflicted or control dogs;
see Fig. 1), this biochemical difference is not likely to constitute a
mechanism that contributes to the higher incidence of arrhythmias that
are initiated in this region. Rather, the lower cAMP levels would more
likely result from an associated (or compensatory) abnormality in this
region of the ventricle. Whereas these measurements exclude a defect in
the pathway for cAMP formation, the measurements of cAMP accumulation
were performed in the presence of a phosphodiesterase inhibitor and do
not entirely exclude an abnormality in the integration of the cAMP
signal in the intact ventricle due to defective cAMP breakdown. Future
experiments that consider a potential defect in cAMP catabolism due to
reduced phosphodiesterase expression as well as interrogate other
molecular targets (ion channels, Ca regulatory proteins) will be key to
our understanding of the action potential changes and arrhythmias that
develop in afflicted animals. The present observation that
1-receptors (not
2) induce abnormalities
of rhythm and calcium handling suggested that
1- and
2-receptors may differ in their signaling to the cAMP
pathway and that only the
1-receptor pathway differs
between cardiomyocytes from control and afflicted tissues.
Clinical implications and future directions.
This study has likely implications for the catecholaminergic
ventricular tachycardias that have been described in human subjects (1, 8). These tend primarily to affect children and
adolescents, an age distribution that is similar to that for the
occurrence of tachycardias and death in the canine model studied here.
The tachycardias are pleomorphic in human subjects and primarily
pleomorphic but occasionally monomorphic in dogs (15). In
neither human nor canine is there a prolongation of the QT
interval on electrocardiogram and neither manifests the pattern typical
of torsades de pointes.
A genetic linkage of the catecholaminergic tachycardias has been
described in human subjects, involving the ryanodine receptor gene,
hRyR2 (13). The linkage of catecholaminergic ventricular tachycardias in humans is to lq42-q43 (18), to which RyR2
maps as well (12, 19). The mechanism for the tachycardia
in humans apparently involves hyperphosphorylation of RyR2 via
-adrenergic receptor-dependent stimulation of protein kinase A
(9). It has been suggested that the mutation of the RyR2
gene increases its sensitivity to calcium, such that
-adrenergic
receptor stimulation leads to calcium overload and tachyarrhythmias
(13). Although the arrhythmia in dogs also is inherited,
the responsible gene or genes have not been identified. Nonetheless,
the involvement of a cAMP/protein kinase A-dependent
1-adrenergic receptor pathway leading to abnormalities
in calcium cycling in afflicted animals is consistent with the defect
described in human subjects.
 |
ACKNOWLEDGEMENTS |
This study was supported by National Heart, Lung, and Blood
Institute Grant HL-28958.
 |
FOOTNOTES |
First published December 13, 2001;10.1152/ajpheart.00871.2001
Address for reprint requests and other correspondence:
M. R. Rosen, Center for Molecular Therapeutics, College of
Physicians and Surgeons of Columbia University, Dept. of Pharmacology,
630 W. 168 St., PH7W-321, New York, NY 10032 (E-mail:
mrr1{at}columbia.edu).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 9 October 2001; accepted in final form 6 December 2001.
 |
REFERENCES |
1.
Coumel, P,
Fidelle J,
Lucet V,
Attuel P,
and
Bouvrain Y.
Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases.
Br Heart J
40, Suppl:
28-37,
1978.
2.
Dae, MW,
Lee RJ,
Ursell PC,
Chin MC,
Stillson CA,
and
Moise NS.
Heterogeneous sympathetic innervation in German shepherd dogs with inherited ventricular arrhythmia and sudden cardiac death.
Circulation
96:
1337-1342,
1997.
3.
Gilmour, RF,
and
Moise NS.
Triggered activity as a mechanism for inherited ventricular arrhythmias in German shepherd dogs.
J Am Coll Cardiol
27:
1526-1533,
1996.
4.
Hewett, K,
Legato MJ,
Danilo P,
and
Robinson RB.
Isolated myocytes from adult canine left ventricle: Ca2+ tolerance, electrophysiology and ultrastructure.
Am J Physiol Heart Circ Physiol
245:
H830-H839,
1983.
5.
Hoffman, BF,
Feinmark SJ,
and
Guo SD.
Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes.
J Cardiovasc Electrophysiol
8:
679-687,
1997.
6.
Hoffman, BF,
Guo SD,
and
Feinmark SJ.
Arrhythmias caused by platelet activating factor.
J Cardiovasc Electrophysiol
7:
120-133,
1996.
7.
Kuznetsov, V,
Pak E,
Robinson RB,
and
Steinberg SF.
2-adrenergic receptor actions in neonatal and adult rat ventricular myocytes.
Circ Res
76:
40-52,
1995.
8.
Leenhardt, A,
Lucet V,
Denjoy I,
Grau F,
Ngoc DD,
and
Coumel P.
Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
Circulation
91:
1512-1519,
1995.
9.
Marx, SO,
Reiken S,
Hisamatsu Y,
Jayaraman T,
Burkhoff D,
Rosenblit N,
and
Marks AR.
PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.
Cell
101:
365-376,
2000.
10.
Möise, NS,
Gilmour RF,
and
Ricco ML.
An animal model of spontaneous arrhythmic death.
J Cardiovasc Electrophysiol
8:
98-103,
1997.
11.
Möise, NS,
Meyers-Wallen V,
Flahive WJ,
Valentine BA,
Scarlett JM,
Brown CA,
Chavkin MJ,
Dugger DA,
Renaud-Farrell S,
Kornreich B,
Schoenborn WC,
Sparks JR,
and
Gilmour RF, Jr.
Inherited ventricular arrhythmias and sudden death in German shepherd dogs.
J Am Coll Cardiol
24:
233-243,
1994.
12.
Otsu, K,
Fujii J,
Periasamy M,
Difilippantonio M,
Uppender M,
Ward DC,
and
MacLennan DH.
Chromosome mapping of five human cardiac and skeletal muscle sarcoplasmic reticulum protein genes.
Genomics
17:
507-509,
1993.
13.
Priori, SG,
Napolitano C,
Tiso N,
Memmi M,
Vignati G,
Bloise R,
Sorrentino V,
and
Danieli GA.
Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergie polymorphic ventricular tachycardia.
Circulation
103:
196-200,
2001.
15.
Sosunov, EA,
Anyukhovsky EP,
Shvilkin A,
Hara M,
Steinberg SF,
Danilo P, Jr.,
Rosen MR,
Möise NS,
Mérot J,
Probst V,
Charpentier F,
Legeay Y,
and
LeMarec H.
Abnormal cardiac repolarization and impulse initiation in German shepherd dogs with inherited ventricular arrhythmias and sudden death.
Cardiovasc Res
42:
65-79,
1999.
16.
Sosunov, EA,
Gainullin RZ,
Möise NS,
Steinberg SF,
Danilo P, Jr.,
and
Rosen MR.
1 and
2-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias.
Cardiovasc Res
48:
211-219,
2000.
17.
Steinberg, SF.
The molecular basis for distinct
-adrenergic receptor subtype actions in cardiomyocytes.
Circ Res
85:
1101-1111,
1999.
18.
Swan, H,
Piippo K,
Viitasalo M,
Heikkila P,
Paavonen T,
Kainulainen K,
Kere J,
Keto P,
Kontula K,
and
Toivonen L.
Arrhythmic disorder mapped to chromosome 1q42.
J Am Coll Cardiol
34:
2035-2042,
1999.
19.
Tunwell, REA,
Wickenden C,
Bertrand BMA,
Shevchenko VI,
Walsh MB,
Allen PB,
and
Lai FA.
The human cardiac muscle ryanodine receptor-calcium release channel: identification, primary structure and topological analysis.
Biochem J
318:
477-487,
1996.
20.
Wit, AL,
and
Rosen MR.
Afterdepolarizations and triggered activity: distinction from automaticity as an arrhythmogenic mechanism.
In: The Heart and Cardiovascular System (2nd ed.), edited by Fozzard HA,
Haber E,
Jennings RB,
Katz AM,
and Morgan HE.. New York: Raven, 1992, vol. 2, p. 2113-2163.
Am J Physiol Heart Circ Physiol 282(4):H1181-H1188
0363-6135/02 $5.00
Copyright © 2002 the American Physiological Society